GLP Watchdog

Brello Health vs GoodRx

Neither Brello Health nor GoodRx has an FDA warning letter on record. No price lines up like for like: Brello Health and GoodRx publish prices for different products.

To see where both sit among the other sellers, read our best weight-loss injection providers board.

By Ruth Calder · Enforcement Editor
Editorially reviewed. Not medical advice · How we verify contentLast reviewed

The record

Brello Health / GoodRx

Brello Health logo

Brello Health

8.1/10

GoodRx logo

GoodRx

7.8/10

FDA warning letters
None on record
None on record
Pharmacy
Brand-name only; no compounding
Lowest standing price
$157.72/moCompounded semaglutide injection, 3-month prepaid plan
$149/moFoundayo (orforglipron) pill
States
40 states and DC
48 states
Checked
Prices captured Record checked October 2026
Prices captured Record checked October 2026
Visit Brello Health
Visit GoodRx

Neither Brello Health nor GoodRx pays us. Links to them earn nothing. Scores: Brello Health 8.1, GoodRx 7.8. How we are paid

What the record shows

  1. 01

    Neither Brello Health nor GoodRx has an FDA warning letter on record.

  2. 02

    Brello Health names SouthEnd Pharmacy, a 503A pharmacy. GoodRx sells brand-name medication only.

  3. 03

    No price lines up like for like: Brello Health and GoodRx publish prices for different products.

  4. 04

    Only Brello Health lists a price for compounded semaglutide injection and compounded tirzepatide injection. Only GoodRx lists a price for brand-name tirzepatide pen and Foundayo (orforglipron) pill.

  5. 05

    Brello Health covers one state GoodRx does not and GoodRx covers nine states Brello Health does not.

  6. 06

    Brello Health holds you to a 3-month prepay (6-month plan optional); GoodRx states you can cancel at any time.

Prices and terms, product by product

A price is set against the other side only for the same product, and only when both are standing monthly or 4-week rates. Those pairs are compared by yearly cost.

Brello Health

GoodRx

Compounded semaglutide injection

$157.72/mo

3-month prepaid plan; not compared

Not sold or not priced
Compounded tirzepatide injection

$176.69/mo

6-month prepaid plan; not compared

Not sold or not priced
Brand-name tirzepatide pen
Not sold or not priced

$299/mo

$3,588 a year

Foundayo (orforglipron) pill
Not sold or not priced

$149/mo

$1,788 a year

Price includes
Medication, clinician visits
Not stated
Cancel any time
No
Yes, stated
Minimum term
3-month prepay (6-month plan optional)
None
Refunds
Full refund before a prescription; $50 fee within 24 hours after; none once dispensed
Services and medication are generally non-refundable

Read off each seller’s own pages. Brello Health: October 25, 2026. GoodRx: October 30, 2026. Every plan and dose we hold is on the full review.

The case for each

The case for Brello Health

8.1/10
  • Sells compounded semaglutide injection and compounded tirzepatide injection, which GoodRx does not price
  • Minimum commitment before you can cancel
  • Lowest price is a 3-month prepaid rate
Visit Brello Health

The case for GoodRx

7.8/10
  • Sells brand-name tirzepatide pen and Foundayo (orforglipron) pill, which Brello Health does not price
  • Lists 48 states against 40
  • States you can cancel at any time
Visit GoodRx

Scores

Brello Health 8.1 · GoodRx 7.8 out of 10. Six weighted parts.

Value25%

6.0A
vs
B
8.7

Effectiveness25%

10.0A
vs
B
10.0

User Experience15%

8.0A
vs
B
5.0

Trust & Safety15%

10.0A
vs
B
6.0

Accessibility10%

8.4A
vs
B
9.7

Support10%

5.5A
vs
B
5.0

The score is the same formula for every seller. Payment does not enter it. Method

Brello Health vs GoodRx: questions

Neither Brello Health nor GoodRx has an FDA warning letter on record. Letters are matched to a seller by company, domain and address, never by a similar name.
Brello Health names SouthEnd Pharmacy, a 503A pharmacy. GoodRx sells brand-name medication only. A 503A pharmacy compounds for named patients on a prescription; a 503B outsourcing facility is registered with FDA and inspected under federal manufacturing rules.
No price lines up like for like: Brello Health and GoodRx publish prices for different products. We only set two prices against each other when they are for the same product and both are standing month-to-month or 4-week rates.
Brello Health has a minimum term (3-month prepay (6-month plan optional)). GoodRx states you can cancel at any time; refunds: services and medication are generally non-refundable.
Neither Brello Health nor GoodRx pays us. Links to them earn nothing. Scores: Brello Health 8.1, GoodRx 7.8.

Other sellers we are paid by

Affiliate partners outside this pair. Each has its own record and review, scored the same way.

Sellers closest to these two

Matched on molecule, form and price. Every pair we list · The register

Brand names on this page are registered marks. Novo Nordisk holds Wegovy®, Ozempic® and Rybelsus®; Eli Lilly holds Zepbound®, Mounjaro® and Foundayo®. Neither company has any tie to GLP Watchdog. Trademarks